Beam Therapeutics (BEAM) EBITDA (2019 - 2026)
Beam Therapeutics (BEAM) posted EBITDA of -$121.14 million for Q2 2026, compared with -$114.61 million a year earlier.
Powered by 
Analysis
Beam Therapeutics (BEAM) EBITDA (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Beam Therapeutics was -$355.78 million; for FY2025, it came in at -$361.4 million.
- In prior years, Beam Therapeutics' EBITDA was -$393.64 million in FY2024, -$156.47 million in FY2023, -$324.33 million in FY2022 and -$385.01 million in FY2021.
- Quarterly EBITDA has run from a low of -$121.25 million in Q3 2025 to a high of $138.22 million in Q4 2023 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$101.61 million (Q1 2026), -$11.78 million (Q4 2025) and -$121.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Beam Therapeutics | 2.60 Bn | -2.09 Bn | - | -121.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -121.08 Mn |
| Mar 31, 2026 | -101.58 Mn |
| Dec 31, 2025 | -11.78 Mn |
| Sep 30, 2025 | -121.25 Mn |
| Jun 30, 2025 | -114.61 Mn |
| Mar 31, 2025 | -113.76 Mn |
| Dec 31, 2024 | -94.59 Mn |
| Sep 30, 2024 | -101.03 Mn |
| Jun 30, 2024 | -99.32 Mn |
| Mar 31, 2024 | -98.70 Mn |
| Dec 31, 2023 | 138.22 Mn |
| Sep 30, 2023 | -103.08 Mn |
| Jun 30, 2023 | -97.33 Mn |
| Mar 31, 2023 | -94.28 Mn |
| Dec 31, 2022 | -85.04 Mn |
| Sep 30, 2022 | -87.83 Mn |
| Jun 30, 2022 | -78.55 Mn |
| Mar 31, 2022 | -72.91 Mn |
| Dec 31, 2021 | -60.85 Mn |
| Sep 30, 2021 | -67.88 Mn |
API Access
Beam Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=BEAM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();